News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Professional Services

Clifford Chance lands role advising pharma giant on Covid-19 vaccine

Pfizer is providing $185m as an upfront payment to BioNTech for their collaboration

Clifford Chance has landed a role advising pharmaceutical giant Pfizer on an agreement to develop and distribute a potential Covid-19 vaccine with cancer drug development group BioNTech.

The Magic Circle law firm announced on 9 April that intellectual property and life sciences partner, Stephen Reese, will take charge of the mandate.

WSJ Logo